Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of AbGn-168H in Patients With Moderate to Severe Active, Anti-TNF Alpha and/or Anti-integrin Refractory Ulcerative Colitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03298022
Recruitment Status : Recruiting
First Posted : September 29, 2017
Last Update Posted : August 26, 2019
Sponsor:
Information provided by (Responsible Party):
AbGenomics International, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 2020
Estimated Study Completion Date : September 2020